Sponsor content
36 result(s) found, displaying 21 to 30
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for BYOOVIZ ranibizumab 10 mg/mL solution for injection vial.
-
Australian public assessment report (AusPar)Byooviz (ranibizumab) for the treatment of neovascular age-related macular degeneration etc.
-
Prescription medicine decision summaryTGA decision: Byooviz (ranibizumab) is approved to treat visual impairment.
-
Prescription medicine registrationActive ingredients: Ranibizumab.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ONTRUZANT trastuzumab 150 mg powder for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for HADLIMA adalimumab (rch) 40 mg solution for injection in pre filled syringe.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for HADLIMA adalimumab (rch) 40 mg solution for injection in PushTouch auto-injector.
-
Prescription medicine registrationActive ingredients: adalimumab.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for RENFLEXIS infliximab 100 mg powder for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for BRENZYS etanercept (rch) 50 mg solution for injection pre-filled syringe.